PDSI dashboard measures and psychotropic medications identified during the study period
| PDSI measure | Number of measures that triggered | Psychotropic medications |
| Anticholinergic antidepressant | 4 | Paroxetine, Noritriptyline |
| Anticholinergic polypharmacy | 5 | Oxybutynin, Tropsium, Atropine, Meclizine |
| Antihistamine use | 6 | Hydroxyzine, Diphenhydramine, Loratidine |
| Antipsychotic use with dementia | 3 | Risperidone, Olanzapine, Quetiapine, Haloperidol |
| Antipsychotic use monitoring | 0 | |
| Benzodiazepine use with dementia | 3 | Clonazepan, Diazepan, Lorazepan, Temazepan |
| Benzodiazepine or sedative use | 2 | Zolpidem, Trazodone |
PDSI, Psychotropic Drug Safety Initiative.